{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:09:26Z","timestamp":1794204566248,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clindermatol.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:37:53Z","timestamp":1742009873000},"page":"644-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prurigo nodularis and acquired perforating dermatosis in chronic kidney disease: Are they the same entity?"],"prefix":"10.1016","volume":"43","author":[{"given":"Rami H.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Coscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.03.011_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2013.228","article-title":"Prurigo nodularis in a peritoneal dialysis patient","volume":"85","author":"Bae","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/jcm11010095","article-title":"Epidemiology, comorbidities, and prescription patterns of Korean prurigo nodularis patients: a multi-institution study","volume":"11","author":"Woo","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0003","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","article-title":"Real-world prevalence of prurigo nodularis and burden of associated diseases","volume":"140","author":"Huang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0004","first-page":"e414","article-title":"2020 guidelines for the diagnosis and treatment of prurigo","volume":"48","author":"Satoh","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0006","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ad.2013.09.014","article-title":"Acquired perforating dermatosis: a report of 8 cases","volume":"105","author":"Gonz\u00e1lez-Lara","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/00015555-2492","article-title":"Acquired reactive perforating dermatosis is a variant of prurigo nodularis","volume":"97","author":"Kestner","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221112561","article-title":"Increased IL-31 expression in serum and tissue protein in prurigo nodularis","volume":"13","author":"Chaowattanapanit","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0009","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s13555-022-00782-2","article-title":"Prurigo nodularis: a review of IL-31RA blockade and other potential treatments","volume":"12","author":"Bewley","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/toxins14030197","article-title":"The serum level of IL-31 in patients with chronic kidney disease-associated pruritus: what can we expect?","volume":"14","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0011","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.2227","article-title":"Impact of chronic kidney disease severity on the risk of prurigo nodularis: a population-based cohort study","volume":"102","author":"Kim","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0012","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0013","article-title":"The expression of the renin-angiotensin-aldosterone system in the skin and its effects on skin physiology and pathophysiology","volume":"70","author":"Aleksiejczuk","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0014","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients","volume":"79","author":"Boozalis","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/bjd.20403","article-title":"Itch in skin of colour: a multicentre cross-sectional study","volume":"185","author":"Sutaria","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120954024","article-title":"Have we just scratched the surface? A narrative review of uremic pruritus in 2020","volume":"7","author":"Martin","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/803752","article-title":"Pruritus in systemic diseases: a review of etiological factors and new treatment modalities","volume":"2015","author":"Tarikci","year":"2015","journal-title":"Sci World J"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xkme.2020.08.011","article-title":"Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients","volume":"3","author":"Sukul","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0019","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3390\/jcm12072474","article-title":"Endogenous Opioid imbalance as a potential factor involved in the pathogenesis of chronic kidney disease-associated pruritus in dialysis patients","volume":"12","author":"Wala-Zieli\u0144ska","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0021","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0022","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","article-title":"Peripheral itch sensitization in atopic dermatitis","volume":"71","author":"Tominaga","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0023","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/toxins13070450","article-title":"Chronic kidney disease-associated itch (CKD-aI) in children-a narrative review","volume":"13","author":"Reszke","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0024","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/genes15020146","article-title":"Dysregulation of the skin-liver axis in prurigo nodularis: an integrated genomic, transcriptomic, and population-based analysis","volume":"15","author":"Marani","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2023.01.019","article-title":"Biomarkers in atopic dermatitis","volume":"151","author":"Bakker","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0026","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jid.2024.02.026","article-title":"Increased systemic levels of centrally acting B-type natriuretic peptide are associated with chronic itch of different types","volume":"144","author":"Nattkemper","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/IJNRD.S65929","article-title":"B-type (brain) natriuretic peptide and pruritus in hemodialysis patients","volume":"7","author":"Shimizu","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0028","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1468-3083.2006.01571.x","article-title":"Acquired perforating dermatosis: clinicopathological features in twenty-two cases","volume":"20","author":"Saray","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0029","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archderm.1985.01660100101025","article-title":"Perforating pseudoxanthoma elasticum associated with chronic renal failure and hemodialysis","volume":"121","author":"Nickoloff","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2133.1996.d01-1062.x","article-title":"Acquired perforating dermatosis in a British dialysis population","volume":"135","author":"Morton","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0031","article-title":"Acquired perforating dermatosis in a patient on peritoneal dialysis: a case report and review of the literature","volume":"2018","author":"Imam","year":"2018","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0032","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1542-4758.2009.00405.x","article-title":"Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis","volume":"14","author":"Hari Kumar","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0033","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3346\/jkms.2004.19.2.283","article-title":"Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus","volume":"19","author":"Hong","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0034","first-page":"161","article-title":"Uremic pruritus in chronic hemodialysis patients","volume":"21","author":"Narita","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0035","series-title":"Acquired Perforating Dermatosis","author":"Harbaoui","year":"2024"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0036","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/acr-23-9","article-title":"Acquired perforating dermatosis in patients on peritoneal dialysis: a report of 3 cases","volume":"7","author":"Viejo-Boyano","year":"2023","journal-title":"AME Case Rep"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0037","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00007611-197502000-00004","article-title":"Prurigo nodularis and uremia","volume":"68","author":"Greer","year":"1975","journal-title":"South Med J"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0038","first-page":"354","article-title":"Prurigo nodularis in a woman with stage-4 chronic kidney disease","volume":"4","author":"Neild","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0039","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archderm.1989.01670200050007","article-title":"Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers","volume":"125","author":"Rapini","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2020.04.027","article-title":"CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management","volume":"5","author":"Verduzco","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212184","article-title":"Quality of life and its predictors among patients with chronic kidney disease: a hospital-based cross sectional study","volume":"14","author":"Kefale","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0042","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00403-020-02148-0","article-title":"The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis","volume":"313","author":"Janmohamed","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0043","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/jdv.16182","article-title":"The treatment of Kyrle's disease: a systematic review","volume":"34","author":"Forouzandeh","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0044","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/ced.14722","article-title":"Clinical characteristics and disease burden in prurigo nodularis","volume":"46","author":"Aggarwal","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14712598.2021.1958777","article-title":"Therapeutic potential of biologics in prurigo nodularis","volume":"22","author":"M\u00fcller","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0046","first-page":"5","article-title":"Prurigo nodularis: review and emerging treatments","volume":"26","author":"Leis","year":"2021","journal-title":"Skin Ther Lett"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2020.05.028","article-title":"New and emerging treatments for inflammatory itch","volume":"126","author":"Erickson","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0048","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","article-title":"Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials","volume":"29","author":"Yosipovitch","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0049","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jdv.17816","article-title":"Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase","volume":"36","author":"Weisshaar","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0052","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/ITT.S316602","article-title":"Immunotargets and therapy for prurigo nodularis","volume":"11","author":"Labib","year":"2022","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.clindermatol.2025.03.011_bib0053","first-page":"825","article-title":"Treatment of acquired reactive perforating dermatosis - a systematic review","volume":"16","author":"Luk\u00e1cs","year":"2018","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2500094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2500094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T02:21:58Z","timestamp":1762395718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X2500094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0738081X2500094X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.03.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prurigo nodularis and acquired perforating dermatosis in chronic kidney disease: Are they the same entity?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}